Nyxoah S.A.

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

B6S7WD106

SEDOL

N/A

CIK

0001857190

www.nyxoah.com

LEI:

FIGI: BBG00X7DCB76

NYXH

Nyxoah S.A.

GICS: - · Sector: - · Sub-Sector: -

NAME

Nyxoah S.A.

ISIN

BE0974358906

TICKER

NYXH

MIC

XBRU

REUTERS

NYXH.BR

BLOOMBERG

NYXH BB

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Mon, 04.11.2024

Nyxoah Appoints John Landry as Chief Financial Officer

Research & Analysis

Fri, 25.10.2024

Research & Analysis

Tue, 15.10.2024

Research & Analysis

Wed, 09.10.2024

REGULATED INFORMATION

Research & Analysis

Mon, 07.10.2024

INSIDE INFORMATION
REGULATED INFORMATION

Research & Analysis

Fri, 27.09.2024

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update

Research & Analysis

Fri, 27.09.2024

REGULATED INFORMATION

Research & Analysis

Thu, 05.09.2024

Nyxoah to Participate in Upcoming Investor Conferences

Research & Analysis

Mon, 02.09.2024

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Research & Analysis

Mon, 15.07.2024

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

Nyxoah S.A.

Nyxoah Appoints John Landry as Chief Financial Officer

Publication relating to transparency notifications

Publication relating to transparency notifications

Information on the total number of voting rights and shares

Nyxoah Raises $27 Million through its At-the-Market Offering

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update

Information on the total number of voting rights and shares

Nyxoah to Participate in Upcoming Investor Conferences

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Newsletter